# David Komander

> David Komander is a Series A investor at Walter and Eliza Hall Institute of Medical Research backing Medical. See 1 investments, check sizes, portfolio and…

- Type: Angel Investor
- Fund: [Walter and Eliza Hall Institute of Medical Research](https://shizune.co/investors/profile/walter-and-eliza-hall-institute-of-medical-research)
- Total investments: 1
- Last investment: Dec 2022
- Lead investor: 0%
- Last updated: Oct 2026

David Komander is a Series A investor at Walter and Eliza Hall Institute of Medical Research focused on Medical and Biopharma.

## Contacts

5 contacts available for David Komander: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/david-komander?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biopharma | 1 | 100% |
| Life Science | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Entact Bio | Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed tocreate enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins. | $81M | Series A | Dec 06, 2022 | https://entactbio.com |

1 of 1 investments shown.

## Co-investors
- [4BIO Capital](https://shizune.co/investors/profile/4bio-capital-partners) — VC Fund, 1 deal together
- [Abingworth](https://shizune.co/investors/profile/abingworth-management) — VC Fund, 1 deal together
- [Arkin Bio Ventures](https://shizune.co/investors/profile/arkin-bio-ventures) — VC Fund, 1 deal together
- [Brandon Capital](https://shizune.co/investors/profile/brandon-capital-partners) — VC Fund, 1 deal together
- [Janus Henderson Investors](https://shizune.co/investors/profile/janus-henderson-investors) — VC Fund, 1 deal together
- [Logos Capital](https://shizune.co/investors/profile/logos-capital) — VC Fund, 1 deal together

## About Walter and Eliza Hall Institute of Medical Research

VC Fund · Parkville, Australia

Walter and Eliza Hall Institute of Medical Research offers discoveries for cancer, infection, aging, medicines and advanced technologies.

2 contacts available at Walter and Eliza Hall Institute of Medical Research.

| Name | Title | Profile |
| --- | --- | --- |
| David Komander | Head, Ubiquitin Signalling Division | https://shizune.co/investors/profile/david-komander |
| Ueli Nachbur | Scientist Entrepreneur | https://shizune.co/investors/profile/ueli-nachbur |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does David Komander invest in?

David Komander invests primarily in Medical, Biopharma and Life Science startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact David Komander?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did David Komander last invest?

The most recent investment recorded for David Komander closed in Dec 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co